Tim Menzen honored by JPharmSci as Outstanding Early Career Scientist

2023/12/15

Tim Menzen honored by JPharmSci® as Outstanding Early Career Scientist

The Editorial Staff and the American Pharmacists Association have been recognizing outstanding outstanding early career scientists for publishing their most original and significant scientific findings in the Journal of Pharmaceutical Sciences.

One of these honored scientists is Tim Menzen, Chief Technology Officer at Coriolis. We warmly congratulate our colleague on this award.

Check out some of Tim's publications here:

Taking subvisible particle quantitation to the limit: Uncertainties and statistical challenges with ophthalmic products for intravitreal injection

Particles in Biopharmaceutical Formulations, Part 2

Characterization of Virus Particles and Submicron-Sized Particulate Impurities in Recombinant Adeno-Associated Virus Drug Product

Combining Machine Learning and Backgrounded Membrane Imaging

Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals

Access full article

News

2024/08/23

Interview with Tim Menzen on Lyphilized Drug Products and the Martian Pharmacy

Tim Menzen in an interview with the medicine maker on the topic of the transportation, storage, and administration of drugs in space

News

2024/06/21

Poster Presentation: PDA Conference Amsterdam 2024

Join our poster presentation in Amsterdam from June 24-25: Challenges in the Analysis of a Pharmaceutical Lentiviral Vector by Orthogonal Physical (Nano)particle Characterization Techniques

News

2024/05/29

Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies

Coriolis Pharma announces the launch of a U.S. entity that allows customers to combine the convenience of a local service with the advantages of international expertise. In parallel Coriolis is also launching two novel platform services for developability assessment and pre-formulation screening.

News

2024/03/06

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.

News

2023/12/19

Modelling The Future Of Lyophilization

Coriolis experts Andrea Arsiccio and Brecht Vanbillemont publish article on lyophilization modelling in "the Medicine Maker".

News

2023/12/18

Coriolis donates to aid organizations

Coriolis spreads the Christmas spirit and donates to organizations that help people in need, fight for a healthy nature, or improve our society as a whole

News

2023/11/06

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

News

2023/10/16

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

News

2023/09/04

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.

News

2023/07/31

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.